The European Medicines Agency’s Committee on Medicines for People has confirmed that an additional dose of COVID-19 vaccines produced by Pfizer or Moderna increases the ability to produce antibodies against the Corona virus in people with weakened immunity. A booster dose may be given at least 28 days after the second dose.
The European Medicines Agency’s Committee on Medicines for People (CHMP) has concluded that an additional dose of the COVID-19 vaccine from BioNTech/Pfizer or Moderna can be given to people with severely weakened immune systems at least 28 days after the second dose.
“Studies showed that an additional dose of these vaccines increased the ability to produce antibodies to the virus that causes COVID-19 in immunocompromised transplant patients,” EMA said in a news release on Monday.
He added: “Although there is no direct evidence that the ability to produce antibodies in these patients is protected against the Corona virus, an additional dose of protection is expected to increase protection in at least some patients. EMA will continue to monitor any data arising from its efficacy.” .
The agency also stressed that the new recommendations do not apply to people who have a properly functioning immune system. In these cases, according to the EMA, booster doses may be considered at least 6 months after the second dose.
Main image source: Carolyn Breemann/PAP/EPA
“Infuriatingly humble musicaholic. Problem solver. Reader. Hardcore writer. Alcohol evangelist.”